Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer

The incorporation of individualized molecular therapeutics into routine clinical practice for both non-small cell lung cancer (NSCLC) and melanoma are amongst the most significant advances of the last decades in medical oncology. In NSCLC activating somatic mutations in exons encoding the tyrosine k...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelleher, Fergal C., Solomon, Benjamin, McArthur, Grant A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251364/
https://www.ncbi.nlm.nih.gov/pubmed/25562798
http://dx.doi.org/10.3390/jpm2020035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251364/
https://www.ncbi.nlm.nih.gov/pubmed/25562798
http://dx.doi.org/10.3390/jpm2020035

Ejemplares similares